182 related articles for article (PubMed ID: 24177701)
21. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
[TBL] [Abstract][Full Text] [Related]
22. Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach.
Hou JQ; Chen SB; Zan LP; Ou TM; Tan JH; Luyt LG; Huang ZS
Chem Commun (Camb); 2015 Jan; 51(1):198-201. PubMed ID: 25388435
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the Binding Insights of Novel Disubstituted Anthraquinone Derivatives with G-Quadruplex DNA to Exhibit Selective Cancer Cell Cytotoxicity.
Roy S; Muniyappa K; Bhattacharya S
ChemMedChem; 2022 Nov; 17(22):e202200436. PubMed ID: 36161519
[TBL] [Abstract][Full Text] [Related]
24. Spectroscopic studies of Thioflavin-T binding to c-Myc G-quadruplex DNA.
Verma S; Ghuge SA; Ravichandiran V; Ranjan N
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 212():388-395. PubMed ID: 30703662
[TBL] [Abstract][Full Text] [Related]
25. Exploration of the selective recognition of the G-quadruplex in the N-myc oncogene by electrospray ionization mass spectrometry.
Li F; Chen H; Zhou J; Yuan G
Rapid Commun Mass Spectrom; 2015 Feb; 29(3):247-52. PubMed ID: 26411622
[TBL] [Abstract][Full Text] [Related]
26. Selective G-quadruplex DNA stabilizing agents based on bisquinolinium and bispyridinium derivatives of 1,8-naphthyridine.
Dhamodharan V; Harikrishna S; Jagadeeswaran C; Halder K; Pradeepkumar PI
J Org Chem; 2012 Jan; 77(1):229-42. PubMed ID: 22126189
[TBL] [Abstract][Full Text] [Related]
27. A mass spectrometric investigation of novel quadruplex DNA-selective berberine derivatives.
Gornall KC; Samosorn S; Tanwirat B; Suksamrarn A; Bremner JB; Kelso MJ; Beck JL
Chem Commun (Camb); 2010 Sep; 46(35):6602-4. PubMed ID: 20714562
[TBL] [Abstract][Full Text] [Related]
28. Utilization of circular dichroism and electrospray ionization mass spectrometry to understand the formation and conversion of G-quadruplex DNA at the human c-myb proto-oncogene.
Fu H; Yang P; Hai J; Li H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():70-76. PubMed ID: 29860170
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometry of G-quadruplex DNA: formation, recognition, property, conversion, and conformation.
Yuan G; Zhang Q; Zhou J; Li H
Mass Spectrom Rev; 2011; 30(6):1121-42. PubMed ID: 21520218
[TBL] [Abstract][Full Text] [Related]
30. Study of binding affinity and selectivity of perylene and coronene derivatives towards duplex and quadruplex DNA by ESI-MS.
Casagrande V; Alvino A; Bianco A; Ortaggi G; Franceschin M
J Mass Spectrom; 2009 Apr; 44(4):530-40. PubMed ID: 19034888
[TBL] [Abstract][Full Text] [Related]
31. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
32. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives.
Chauhan A; Paladhi S; Debnath M; Dash J
Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597
[TBL] [Abstract][Full Text] [Related]
33. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
34. Interaction of pyrrolobenzodiazepine (PBD) ligands with parallel intermolecular G-quadruplex complex using spectroscopy and ESI-MS.
Raju G; Srinivas R; Reddy VS; Idris MM; Kamal A; Nagesh N
PLoS One; 2012; 7(4):e35920. PubMed ID: 22558271
[TBL] [Abstract][Full Text] [Related]
35. Design and Synthesis of Xanthone Analogues Conjugated with Aza-aromatic Substituents as Promising G-Quadruplex Stabilizing Ligands and their Selective Cancer Cell Cytotoxic Action.
Roy S; Chakraborty N; Maiti B; Muniyappa K; Bhattacharya S
Chembiochem; 2023 Feb; 24(4):e202200609. PubMed ID: 36455103
[TBL] [Abstract][Full Text] [Related]
36. Visualization of ligand-induced c-MYC duplex-quadruplex transition and direct exploration of the altered c-MYC DNA-protein interactions in cells.
Yuan JH; Tu JL; Liu GC; Chen XC; Huang ZS; Chen SB; Tan JH
Nucleic Acids Res; 2022 May; 50(8):4246-4257. PubMed ID: 35412611
[TBL] [Abstract][Full Text] [Related]
37. Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.
Deng N; Wickstrom L; Cieplak P; Lin C; Yang D
J Phys Chem B; 2017 Nov; 121(46):10484-10497. PubMed ID: 29086571
[TBL] [Abstract][Full Text] [Related]
38. A Competitive Pull-Down Assay Using G-quadruplex DNA Linked Magnetic Nanoparticles To Determine Specificity of G-quadruplex Ligands.
Panda D; Saha P; Chaudhuri R; Prasanth T; Ravichandiran V; Dash J
Anal Chem; 2019 Jun; 91(12):7705-7711. PubMed ID: 31095910
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
